$60.48
-2.27-3.62%
At Close: -
$60.75
0.270.45%
After Hours: 6:38 PM EDT
15 minutes delayed
Comments
Loading...
CRISPR Therapeutics
CRSPNASDAQ
CRISPR Therapeutics (NASDAQ:CRSP) Stock, Earnings Estimates, EPS, And Revenue
CRISPR Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 5
EPS Estimate
$-1.520
Quarterly Revenue Estimate
$3.5M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$270M
Analyze the earnings history of CRISPR Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRSP | CRISPR Therapeutics | -$0.98 | -$1.52 | — | — | $70.00M | $3.54M | — | — | 08/05/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.67 | -$1.42 | -$1.43 | -0.70% | $100.00M | $28.11M | $504.00K | -98.21% | 05/08/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.41 | -$0.07 | $1.10 | 1671.43% | $6.00K | $131.63M | $201.21M | 52.86% | 02/21/2024 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.24 | -$1.96 | -$1.41 | 28.06% | $94.00K | $8.43M | $0.00 | -100.00% | 11/06/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.40 | -$2.12 | -$0.98 | 53.77% | $158.00K | $1.71M | $70.00M | 3993.57% | 08/07/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$2.32 | -$1.70 | -$0.67 | 60.59% | $940.00K | $22.98M | $100.00M | 335.16% | 05/08/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.84 | -$2.30 | -$1.41 | 38.70% | $12.90M | $7.12M | $6.00K | -99.92% | 02/21/2023 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.67 | -$2.29 | -$2.24 | 2.18% | $824.00K | $1.62M | $94.00K | -94.20% | 11/01/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | $9.44 | -$2.23 | -$2.40 | -7.62% | $900.70M | $2.06M | $158.00K | -92.33% | 08/08/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.51 | — | -$2.32 | — | $539.00K | — | $940.00K | — | 05/09/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.50 | -$1.77 | -$1.84 | -3.95% | $370.00K | $2.27M | $12.90M | 468.24% | 02/15/2022 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.32 | -$1.76 | -$1.67 | 5.11% | $148.00K | $1.12M | $824.00K | -26.43% | 11/03/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.30 | $3.52 | $9.44 | 168.18% | $44.00K | $420.92M | $900.70M | 113.98% | 07/29/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.15 | -$1.47 | -$1.51 | -2.72% | $157.00K | $1.14M | $539.00K | — | 04/27/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | $0.51 | -$1.27 | -$1.50 | -18.11% | $77.02M | $2.32M | $370.00K | -84.05% | 02/16/2021 | Get Alert |
| CRSP | CRISPR Therapeutics | $2.40 | -$1.18 | -$1.32 | -11.86% | $211.93M | $2.06M | $148.00K | -92.82% | 10/28/2020 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.01 | -$0.95 | -$1.30 | -36.84% | $318.00K | $18.12M | $44.00K | -99.76% | 07/27/2020 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.93 | — | -$1.15 | — | $328.00K | — | $157.00K | — | 04/28/2020 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.92 | — | $0.51 | — | $115.00K | — | $77.02M | — | 02/12/2020 | Get Alert |
| CRSP | CRISPR Therapeutics | -$1.07 | — | $2.40 | — | $563.00K | — | $211.93M | — | 10/28/2019 | Get Alert |
| CRSP | CRISPR Therapeutics | -$0.82 | -$0.90 | -$1.01 | -12.22% | $1.09M | $3.94M | $318.00K | -91.93% | 07/29/2019 | Get Alert |
CRISPR Therapeutics (CRSP) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $-1.43 | $-1.42 | -0.70 % |
| Dec 2023 | 2024-02-21 | $1.10 | $-0.07 | 1671.4 % |
| Sep 2023 | 2023-11-06 | $-1.41 | $-1.96 | 28.1 % |
| Jun 2023 | 2023-08-07 | $-0.98 | $-2.12 | 53.8 % |
CRISPR Therapeutics (CRSP) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-08 | $504.00K | $28.11M | -98.2 % |
| Dec 2023 | 2024-02-21 | $201.21M | $131.63M | 52.9 % |
| Sep 2023 | 2023-11-06 | $0 | $8.43M | -100.0 % |
| Jun 2023 | 2023-08-07 | $70.00M | $1.71M | 3993.6 % |
FAQ
When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?
CRISPR Therapeutics (CRSP) is scheduled to report earnings on August 5, 2024. The last reported earnings were for reported on May 8, 2024 for Q1.
What were the latest earnings per share (EPS) for CRISPR Therapeutics (NASDAQ:CRSP)?
The Actual EPS was $-1.43, which missed the estimate of $-1.42.
What were CRISPR Therapeutics’s (NASDAQ:CRSP) revenues?
The Actual Revenue was $504K, which missed the estimate of $28.1M.
Browse earnings estimates, EPS, and revenue on all stocks.